Moleculin Biotech Inc (MBRX)

[pfelgueiras]

“WHO KNOWS”, …if the reason of SEC, temporary suspension of $MBRX on NASDAQ during 10 days, might be related to some big biotech company wants to buy $MBRX?

Perhaps SEC wants to confirm, all information about the Potential Drug Candidate for Covid-19.

$MBRX have a great pipeline development, which included drugs for FDA approval for treatment of Acute Myeloid Leukemia, Skin Cancer, Brain Tumors, Pancreatic Cancer, and now also a Potential Drug Candidate for COVID-19.

Remember also on May 3, 2020 $MBRX announced that Dr. Richard Whitley join to its Science Advisory Board to guide its development strategy for WP1122 for the potential treatment of COVID-19 and other viral diseases.
Whitley it will be the key to FDA he invented remdesivir.

It wouldn't be a surprise to me, if it could happen something similar to $MBRX, like what happened this year to $FTSV.

$FTSV was Acquired on February 23, 2020 by Gilead ($GILD) for $4.9 Billion ($95.50 per share), and FTSV on October 23, 2019 she had a 52 Week low price of $5.53.

The future will tell if something is on the way!